Assess the potential impact of a drug that enhances effector enzyme activity in GPCR pathways.

Enhanced effector enzyme activity would inhibit ligand binding to GPCRs.

Enhanced effector enzyme activity would decrease secondary messenger production, dampening cellular responses.

Enhanced effector enzyme activity would have no effect on secondary messenger production.

Enhanced effector enzyme activity would increase secondary messenger production, potentially amplifying cellular responses.